Our mission is to extend and improve the quality of life through technology powered by your cells.
GoodCell is a revolutionary health technology platform powered by science that helps you proactively identify, track and respond to health concerns through personal biobanking, health screening, and genetic testing.
Our unique offering is rooted in your blood. We decode the complexity of individual health through the power of your cells, which provide genetic and biological information for use today as well as banked biomaterials for potential use in the future.
Backed by cutting-edge scientists, we profile your health through markers in your blood, the dynamic nature of genes and stem cells. As stem cell science becomes stem cell medicine, GoodCell is your personalized investment to bank on a healthier future for you and for your family.
Who We Are
Founded in 2016, GoodCell is comprised of a team of cutting-edge scientists, researchers from Harvard, Mass General Hospital, Dana Farber Cancer Institute and Stanford, experienced doctors, and innovative entrepreneurs. We’re surrounded by experts in science, technology, and business who inspire us to be progressive every day.
Our Scientific Advisors
Simon H. Stertzer Endowed Professor, Stanford School Of Medicine.
Director, Stanford Cardiovascular Institute
Professor Of Stem Cell And Regenerative Biology, Harvard University.
Principal Investigator, Harvard Stem Cell Institute.
Director, Stem Cell Biology, Stanley Center For Psychiatric Research At The Broad Institute.
Dorothy And Milton Flier Professor Of Biomedical Science And Genetics, Harvard Medical School.
Director, Genomic Neurobiology, Stanley Center For Psychiatric Research At The Broad Institute.
Professor Of Medicine, Harvard University.
Professor Of Medicine, Dana-Farber Cancer Institute.
Executive Director, Connell-O’Reilly Cell Manipulation Core Facility At Dana-Farber Cancer Institute.